We are excited to announce that CSI will be attending the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas,...

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our...

A Leading Biotech Client's Challenge A leading biotech client approached CSI to assist in sourcing the comparator drug Lucentis for a...

We’re excited to announce that Stephan Muetze , Director of Project Management, and Yasmine Clemson , Project Management and Marketing...

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine!  This recognition is...

Ensuring Efficiency, Compliance and Success Full supply chain management in clinical trial supply encompasses the comprehensive oversight...

CSI's Director of Strategy, Andrea Giochetta is attending BioNJ's BioPartnering Conference at the Liberty Science Centre in New Jersey on...

Ancillaries play a crucial role in ensuring the smooth execution of clinical trials, encompassing a broad range of items, materials and...

Ryvu Therapeutics Announces Entering into Agreement with Clinical Services International (CSI) in the Area of Securing Venetoclax Supply...

The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...

Here is a success story that demonstrates how CSI can support your clinical trial supplies. CSI managed to compress six months of...

Innovation in oncology drug development is granting cancer patients access to life-changing therapies. The industry continues to conduct...

How CSI’s scientific insight delivered an agile sourcing model and substantial cost savings for a listed biotechnology company’s global...

Unwrap CSI's Twelve Case Studies of Christmas 2020 has been a challenging year, with product shortages, borders closing, more...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more...

How CSI leveraged relationships with multiple manufacturers to urgently supply large quantities of a generic drug to a global Phase 3...